Advertisement

Korean Journal of Chemical Engineering

, Volume 23, Issue 5, pp 819–826 | Cite as

Agglomeration behavior of anhydrous L-ornithine-L-aspatate crystals during semi-batch drowning-out crystallization

  • Woochan Hyung
  • Yehoon Kim
  • Seungjoo Haam
  • Kee-Kahb Koo
Article

Abstract

Crystallization of L-ornithine-L-aspartate (LOLA) by drowning out was carried out to produce the anhydrous form of agglomerates. The primary crystal size in the agglomerate remained unchanged after completion of the crystallization. The LOLA aqueous solution introduced into the system was immediately dispersed and cluster coagulated on the surface of the crystals. On the surface of the crystals, a cluster reached critical nuclei size, nucleated and intergrowth to form agglomerates. It was proposed that a spherical agglomeration occurred during secondary nucleation by coagulation model and intergrowth. The agglomerates size and size distribution were varied with the process parameters. The agglomerate sizes of LOLA crystals appeared to be ruled not only by secondary nucleation rate but also by the mass of suspended agglomerates. Moreover, the agglomeration rates of fine particles were higher than the agglomeration rates of large agglomerates. Using these properties, the uniform agglomerates size distribution could be obtained.

Key words

Drowning-Out L-Ornithine-L-Aspartate Pseudopolymorph Agglomeration Impurity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brittain, H. G.,Polymorphism in pharmaceutical solids, Marcel Dekker, New York (1999).Google Scholar
  2. Charmolue, H. and Rousseau, R. W., “L-Serine obtained by methanol addition in batch crystallization,”AIChE J.,37, 1121 (1991).CrossRefGoogle Scholar
  3. Choe, J., Kwon, Y. and Kim, Y., “Micromixer as a continuous flow reactor for the synthesis of a pharmaceutical intermediate,”Korean J. Chem. Eng.,20, 268 (2003).CrossRefGoogle Scholar
  4. Chulia, D., Deleuil, M. and Pourcelot, Y.,Powder technology and pharmaceutical processes, Elsevier, Amsterdam (1994).Google Scholar
  5. David, A. B., Susan, R. D. and Ka, M. N., “Synthesis of drowning-out crystallization-based separations,”AIChE J.,43, 91 (1997).CrossRefGoogle Scholar
  6. Kage, H., Dohzaki, M. and Ogura, H., “Powder coating efficiency of small particles and their agglomeration in circulating fluidized bed,”KoreanJ. Chem. Eng.,16, 630 (1999).CrossRefGoogle Scholar
  7. Kawashima, Y., Okumura, M. and Takenaka, H., “Spherical crystallization: Direct spherical agglomeration of salicylic acid crystals during crystallization,”Science,216, 1127 (1982).CrossRefGoogle Scholar
  8. Kim, Y. H., Haam, S., Koo, K.-K., Shul, Y. G., Son, J. H. and Jung, J. K., “Representation of solid-liquid equilibrium of L-ornithine-L-aspartate+water+methanol system using the chen model for electrolyte solution,”J. Chem. Eng. Data,46, 1387 (2001).CrossRefGoogle Scholar
  9. Kim, Y. H., Haam, S., Shul, Y. G., Kim, W. S., Jung, J. K., Eun, H.-C. and Koo, K.-K., “Pseudopolymorphic crystallization of L-ornithine-L-aspartate by drowning out,”I&EC,42, 883 (2003).Google Scholar
  10. Kim, Y. H., Hyung, W. C., Haam, S. J. and Koo, K. K., “The effect of initial precipitates on the induction period of L-ornithine-L-aspartate during semi-batch drowning out crystallization,”J. of Crystal Growth, In press (2006).Google Scholar
  11. Kim, Y., Haam, S. and Kim, W. S., “Parameters determining the agglomeration behavior of anhydrous L-ornithine-L-aspartate (LOLA) crystals prepared by drowning out crystallization,”Korean J. Chem. Eng.,20, 1111 (2003).CrossRefGoogle Scholar
  12. Mulline, J. W.,Crystallization, Butterworth-Heinemann, London (1993).Google Scholar
  13. Myerson, A. S.,Handbook of industrial crystallization, Butterworth-Heinemann, London (1993).Google Scholar
  14. Randolph, A. D. and Larson, M. A.,Theory of particulate processes, Academic press (1971).Google Scholar
  15. Rees, C. J., Oppong, K., Al Mardini, H., Hudson, M. and Record, C. O., “Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: A double blind, placebo controlled trial,”Gut,47(4), 571 (2000).CrossRefGoogle Scholar
  16. Rose, C., Michalak, A., Pannunzio, P., Therrien, G., Quack, G., Kircheis, G. and Butterworth, R. F., “L-Ornithine-L-aspartate in experimental portal-systemic encephalopathy: Therapeutic efficacy and mechanism of action,”Metabolic Brain Disease,13(2), 147 (1998).CrossRefGoogle Scholar
  17. Rose, C., Michalak, A., Rao, K. V., Quack, G., Kircheis, G. and Butterworth, R. F., “L-Ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure,”Hepatology (Baltimore, Md.),30(3), 636 (1999).Google Scholar
  18. Szabó-Révész, P., GöczÕ, H., Pintye-Hódi, K., Kasa Jr, P., ErÕs, I., Hasznos-Nezdei, M. and Farkas, B., “Development of spherical crystal agglomerates of an aspartic acid salt for direct tablet making,”Powder Technology,114, 118 (2001).CrossRefGoogle Scholar
  19. Vogels, B. A., Karlsen, O. T., Mass, M. A., Boveé, W. M. and Chamuleau, R. A., “L-Ornithine vs. L-ornithine-L-aspartate as a treatment for hyperammonemia-induced encephalopathy in rats,”J. of Hepatology,26(1), 174 (1997).CrossRefGoogle Scholar
  20. Wolfgang, B., “Nucleation phenomena during the crystallization and precipitation of aecarnil,”J. of Crystal Growth,198–199, 1307 (1999).Google Scholar

Copyright information

© Korean Institute of Chemical Engineering 2006

Authors and Affiliations

  • Woochan Hyung
    • 1
  • Yehoon Kim
    • 1
  • Seungjoo Haam
    • 1
  • Kee-Kahb Koo
    • 2
  1. 1.Department of Chemical EngineeringYonsei UniversitySeoulKorea
  2. 2.Department of Chemical and Biomolecular EngineeringSogang UniversitySeoulKorea

Personalised recommendations